Teratogenic effects of benzodiazepine use during pregnancy*

https://doi.org/10.1016/S0022-3476(89)80619-5Get rights and content

Eight children exposed in utero to benzodiazepines had characteristic dysmorphic features, growth aberrations, and central nervous system abnormalities from birth. Their dysmorphic characteristics resembled those of the fetal alcohol syndrome, although they had greater focal involvement of cranial nerves, with a sullen and expressionless face, and they more often had impairment of vitality at birth. One infant died and at autopsy had varying degrees of distortion of neuronal migration, with concomitant heterotopias. Five of the eight mothers had regularly consumed benzodiazepines, and the three remaining mothers had blood samples during pregnancy revealing benzodiazepine concentrations indicative of regular use. Our findings indicate that maternal consumption of benzodiazepines may be teratogenic in humans.

References (44)

  • CorrodiH et al.

    Minor tranquillizers, stress and central catecholamine neurons

    Brain Res

    (1971)
  • LaegreidL et al.

    Abnormalities in children exposed to benzodiazepines in utero

    Lancet

    (1987)
  • LaegreidL et al.

    Benzodiazepine overconsumption in pregnancy

    Lancet

    (1987)
  • OlegrdR et al.

    Effect on the child of alcoholic abuse during pregnancy

    Acta Paediatr Scand Suppl

    (1979)
  • StreissguthAP et al.

    Tertogenic effect of alcohol in humans and laboratory animals

    Science

    (1980)
  • CreeJE et al.

    Diazepam in labour: its metabolism and effect on the clinical condition and thermogenesis of the newborn

    Br Med J

    (1973)
  • KarlbergP et al.

    Clinical analysis of causes of death with emphasis on perinatal mortality

  • BjerreB et al.

    Significance of obstetric factors in prognosis of low birth weight children

    Acta Paediatr Scand

    (1976)
  • PruittAW et al.

    Neonatal drug withdrawal

    Pediatrics

    (1983)
  • NorveniusG

    Sudden infant death syndrome in Sweden in 1973–1977 and 1979

    Acta Paediatr Scand

    (1987)
  • StrömlandK

    Eye findings in the fetal alcohol syndrome

    Acta Ophthalmol (Suppl) (Copenh)

    (1985)
  • HillestadL et al.

    Diazepam metabolism in normal man

    Clin Pharmacol Ther

    (1974)
  • Cited by (117)

    • Drugs Affecting the Central Nervous System

      2020, Drug-Induced Ocular Side Effects, Eigtht Edition
    • Passive Addiction and Teratogenic Effects

      2018, Volpe's Neurology of the Newborn
    • Prenatal exposure to anxiolytic and hypnotic medication in relation to behavioral problems in childhood: A population-based cohort study

      2017, Neurotoxicology and Teratology
      Citation Excerpt :

      Little is known about possible long-term consequences of prenatal BBRM exposure and child behavior. Prenatal exposure to benzodiazepines has been associated with a delay in development and attention-deficit and hyperactivity symptoms (Laegreid et al., 1989; Viggedal et al., 1993), but has not been associated with children's school behavior (Stika et al., 1990). In the current study, the associations of prenatal BBRM exposure with childhood ODD symptoms and aggressive behavior were confounded by maternal anxiety during pregnancy.

    • Percutaneous nephrostomy tube placement in pregnancy: Care of the mother and unborn child

      2016, Journal of Radiology Nursing
      Citation Excerpt :

      In a meta-analysis, on the use of benzodiazepines during the first trimester of pregnancy, there was a significant increase in risk of oral cleft palate. However, other studies have failed to confirm this association (Dolovich et al., 1998; Ornoy et al., 1998; Laegreid et al., 1989). Diazepam should not be used for sedation in pregnant women as the use of diazepam during pregnancy has been associated with cleft palate and, when used later in pregnancy, neurobehavioral disorders (Dolovich et al., 1998; Ornoy et al., 1998; Laegreid et al., 1989).

    • Poisonings and toxins

      2015, Drugs During Pregnancy and Lactation: Treatment Options and Risk Assessment: Third Edition
    View all citing articles on Scopus
    *

    Supported by grants from the Delegation for Social Research, the Swedish Ministry of Health and Welfare (Socialdepartementet), the Wilhelm and Martina Lundgren Foundation, and the Swedish Medical Research Council (grant No. 07121).

    View full text